Related Experiment Videos
Mycotic morbidity--an occupational risk for mycologists
1Bureau of Laboratories, S.C. Department of Health and Environmental Control, Columbia 29202.
Mycopathologia
|September 1, 1987
Summary
Classical mycologists face higher risks of laboratory-acquired fungal infections. Implementing good laboratory practices is crucial for preventing mycosis in researchers studying fungal pathogens.
Area of Science:
- Medical Mycology
- Laboratory Safety
- Infectious Diseases
Background:
- Understanding the routes of human infection by systemic fungal pathogens is established.
- Classical mycologists may encounter increased risk compared to medical mycologists.
- Emerging fungal pathogens and immunocompromised populations heighten laboratory infection risks.
Purpose of the Study:
- To outline principles for developing good laboratory practices for classical mycological researchers.
- To describe minimal safety measures to prevent fungal infections (mycotic morbidity) in laboratory settings.
Main Methods:
- Review of known infection pathways for systemic mycoses.
- Application of established infection control principles to mycological laboratory work.
- Description of essential safety practices for handling fungal pathogens.
Main Results:
- Classical mycologists are identified as a potentially higher-risk group for laboratory-acquired infections.
- Established principles of mycosis transmission can inform laboratory safety protocols.
- Specific safety practices are outlined to mitigate risks associated with novel fungal pathogens.
Conclusions:
- Good laboratory practices, informed by known infection routes, are essential for classical mycologists.
- Proactive implementation of safety measures is necessary to prevent laboratory-associated fungal infections.
- Adapting safety protocols is crucial due to new fungal threats and susceptible populations.